Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Indirect and mixed treatment comparisons in arthritis research.

Ades AE, Madan J, Welton NJ.

Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv5-9. doi: 10.1093/rheumatology/ker241. Review.

2.

Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research.

Welton NJ, Madan J, Ades AE.

Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv19-25. doi: 10.1093/rheumatology/ker242.

3.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
4.

Network meta-analysis for comparing treatment effects of multiple interventions: an introduction.

Catalá-López F, Tobías A, Cameron C, Moher D, Hutton B.

Rheumatol Int. 2014 Nov;34(11):1489-96. doi: 10.1007/s00296-014-2994-2. Epub 2014 Apr 2. Review.

PMID:
24691560
5.

Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans.

Barton P.

Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv32-iv38. doi: 10.1093/rheumatology/ker244.

6.

Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisal.

Yang H, Craig D, Epstein D, Bojke L, Light K, Bruce IN, Sculpher M, Woolacott N.

Pharmacoeconomics. 2012 Apr;30(4):257-70. doi: 10.2165/11595920-000000000-00000. Review.

PMID:
22283690
7.

New methods for determining comparative effectiveness in rheumatoid arthritis.

Yun H, Curtis JR.

Curr Opin Rheumatol. 2013 May;25(3):325-33. doi: 10.1097/BOR.0b013e32835fd8c0. Review.

8.

Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.

Devine EB, Alfonso-Cristancho R, Sullivan SD.

Pharmacotherapy. 2011 Jan;31(1):39-51. doi: 10.1592/phco.31.1.39.

PMID:
21182357
9.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Clark W, Jobanputra P, Barton P, Burls A.

Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.

10.

Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.

Otten MH, Anink J, Spronk S, van Suijlekom-Smit LW.

Ann Rheum Dis. 2013 Nov;72(11):1806-12. doi: 10.1136/annrheumdis-2012-201991. Epub 2012 Nov 21. Review.

PMID:
23172748
11.

Comparative effectiveness of rheumatoid arthritis therapies.

Finckh A.

Curr Rheumatol Rep. 2010 Oct;12(5):348-54. doi: 10.1007/s11926-010-0123-0.

PMID:
20652775
12.

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.

Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, Gossec L, Landewe R, Smolen JS, Buch MH.

Ann Rheum Dis. 2014 Mar;73(3):516-28. doi: 10.1136/annrheumdis-2013-204577. Epub 2014 Jan 7. Review. Erratum in: Ann Rheum Dis. 2015 Jan;74(1):320.

PMID:
24399231
13.
14.

Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials.

Steiman AJ, Pope JE, Thiessen-Philbrook H, Li L, Barnabe C, Kalache F, Kung T, Bessette L, Flanagan C, Haraoui B, Hochman J, Leclercq S, Mosher D, Thorne C, Bykerk V.

Rheumatol Int. 2013 May;33(5):1105-20. doi: 10.1007/s00296-012-2619-6. Epub 2013 Jan 6. Review.

PMID:
23292213
15.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, Lühmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

16.

Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons.

Jansen JP, Crawford B, Bergman G, Stam W.

Value Health. 2008 Sep-Oct;11(5):956-64. doi: 10.1111/j.1524-4733.2008.00347.x. Epub 2008 May 16. Review.

17.

Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.

Goulabchand R, Mouterde G, Barnetche T, Lukas C, Morel J, Combe B.

Ann Rheum Dis. 2014 Feb;73(2):414-9. doi: 10.1136/annrheumdis-2012-202641. Epub 2013 Jan 25. Review.

PMID:
23355079
18.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

19.

[Is it possible to compare different studies on efficacy of biologicals in patients with rheumatoid arthritis? : mixed treatment comparison as a new tool for indirect comparison of clinical studies].

Krüger K, Hellmich B, Rubbert-Roth A, Müller-Ladner U, Kielhorn A.

Z Rheumatol. 2011 Aug;70(6):517-24. doi: 10.1007/s00393-011-0827-1. Review. German.

PMID:
21698473
20.

Rituximab for the treatment of rheumatoid arthritis.

Bagust A, Boland A, Hockenhull J, Fleeman N, Greenhalgh J, Dundar Y, Proudlove C, Kennedy T, Moots R, Williamson P, Dickson R.

Health Technol Assess. 2009 Sep;13 Suppl 2:23-9. doi: 10.3310/hta13suppl2/04. Review.

Items per page

Supplemental Content

Write to the Help Desk